Drug uptake and cellular targets of hydroxymethylacylfulvene (HMAF)
- 7 June 1999
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 58 (2) , 217-225
- https://doi.org/10.1016/s0006-2952(99)00085-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Reaction of antitumor hydroxymethylacylfulvene (HMAF) with thiolsTetrahedron, 1997
- REDOX REGULATION OF CELLULAR ACTIVATIONAnnual Review of Immunology, 1997
- (Hydroxymethyl)acylfulvene: An Illudin Derivative with Superior Antitumor PropertiesJournal of Natural Products, 1996
- Induction of internucleosomal DNA fragmentation by carcinogenic chromate: relationship to DNA damage, genotoxicity, and inhibition of macromolecular synthesis.Environmental Health Perspectives, 1994
- Characterization of illudin S sensitivity in DNA repair-deficient chinese hamster cells: Unusually high sensitivity of ercc2 and ercc3 DNA helicase-deficient mutants in comparison to other chemotherapeutic agentsBiochemical Pharmacology, 1994
- Structure-activity relationships of illudins: analogs with improved therapeutic index.The Journal of Organic Chemistry, 1992
- On the mechanism of toxicity of illudins: the role of glutathioneChemical Research in Toxicology, 1990
- Preclinical Evaluation of Illudins as Anticancer Agents: Basis for Selective CytotoxicityJNCI Journal of the National Cancer Institute, 1990
- The mode of action of cytotoxic and antitumor 1-nitroacridines. II. In vivo enzyme-mediated covalent binding of a 1-nitroacridine derivative, ledakrin or nitracrine, with DNA and other macromolecules of mammalian or bacterial cellsChemico-Biological Interactions, 1983
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976